You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tarlatamab

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small Cell Lung Cancer Trial (Tarlatamab)

Available
  • Small Cell Lung Cancer
  • Tarlatamab
  • (no location specified)
Sep 26, 2023

Small Cell Lung Cancer (SCLC) Trial (Tarlatamab, Lurbinectedin, Topotecan)

Not yet recruiting
  • Small Cell Lung Cancer (SCLC)
  • Tarlatamab
  • +3 more
  • (no location specified)
Feb 21, 2023

Extensive Stage Small Cell Lung Cancer Trial (Tarlatamab, Carboplatin, Etoposide)

Recruiting
  • Extensive Stage Small Cell Lung Cancer
  • Tarlatamab
  • +4 more
  • Los Angeles, California
  • +37 more
Feb 1, 2023

Neuroendocrine Prostate Cancer Trial in Worldwide (Tarlatamab)

Recruiting
  • Neuroendocrine Prostate Cancer
  • Tarlatamab
  • Phoenix, Arizona
  • +19 more
Aug 11, 2022

Relapsed/Refractory Small Cell Lung Cancer Trial in Worldwide (Tarlatamab)

Recruiting
  • Relapsed/Refractory Small Cell Lung Cancer
  • Tarlatamab
  • Birmingham, Alabama
  • +78 more
Jan 18, 2023

Small Cell Lung Cancer Trial in Worldwide (Tarlatamab, AMG 404)

Recruiting
  • Small Cell Lung Cancer
  • Tarlatamab
  • AMG 404
  • Chicago, Illinois
  • +13 more
Jul 27, 2022

Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer Trial in Worldwide (Tarlatamab, Placebo)

Not yet recruiting
  • Limited Stage Small Cell Lung Cancer
  • Small Cell Lung Cancer
  • Tarlatamab
  • Placebo
  • Minneapolis, Minnesota
  • +124 more
Oct 31, 2023